Microfluidics POC Coagulation Testing
The coagulation profile of a trauma patient can change rapidly. This is of great concern for emergency medicine technicians and doctors.
The current practice to test is slow, and does not consider blood cell biology. The coagulation testing is done remotely, and includes plasma testing only.
Solution: We have developed the only point-of-care rapid microfluidic coagulation test based on blood cell properties that minimizes diagnostic time and improves treatment. A portable, point-of-care test, repeatable over time, makes use of a device already in place.
The patent for this device is owned by collaborators at Wyss Institute. It is suitable for patients being treated in surgery, ICU, and ER situations.
Quotes
Thoughts from our board
"Central and Eastern Europe are emerging as high-tech hotbeds. Silicon Valley tech leaders like myself are exploring, and investing in, a range of exciting possibilities from this region. INNES offers tomorrow’s tech superstars a platform to develop and commercialize products and services while offering global investors access to a new pool of opportunity."
- Laszlo Horvath -
In 1995, Laszlo placed the first online advertising programs on AOL – proving the Internet could be a money maker. He is President and co-founder of ActiveMedia.
"INNES is tapping into an exciting new world of opportunity with the opening of their Craiova innovation center. A new tech boom is happening in Central and Eastern Europe and INNES is poised to help internationalize exciting new companies from this region."
- Jozsef Szamosfavi -
A Hungarian native with a strong Washington, DC network, Jozef created, and successfully manages trade platforms for under-banked, mid-market companies at Interlink Capital Strategies.